IMULAN Prepares To Initiate Trials For Atopic Dermatitis In Dogs
IMULAN BioTherapeutics, LLC announced they are prepared to commence with regulated trials to complete work on the T-Cell Receptor peptide immunomodulator, for atopic dermatitis in dogs. Canine atopic dermatitis is a very prevalent condition in dogs, thought to affect up to 5 percent of the dog population. Clinical signs of atopic dermatitis include pruritus (itching) [...]
Also tagged Atopic Dermatitis, Clinical Signs, Dermatitis, Immunomodulator, Llc, Peptide, Population, Prevalent Condition, Pruritus Itching, Pyoderma, Skin Infections, T Cell Receptor, Topical Skin
